Engineered cells that repair arthritis using disease-aware signals
Official title: Engineered cells as agents of arthritis therapy governed by artificial signaling
Funded at Vanderbilt University · NIH-11384709 · Data updated 2026-11-12
A research grant seeks to use specially designed cells that sense damaged joint environments and deliver regenerative therapy for arthritis, with the goal of improving cartilage and joint health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Vanderbilt University NIH-funded |
| Lab location | 1 site (Nashville, UNITED STATES) |
| Project start | September 17, 2024 |
| Project end | July 31, 2029 |
| Funding year | 2026 |
| Award (this year) | $399,680 |
| NIH project number | 5R01AR083437-03 |
| Project ID | NIH-11384709 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are people with osteoarthritis or related joint degeneration who are exploring disease-modifying therapies.
✕Less likely to help
People without joint degeneration or those in very early or late disease stages may not benefit.</patients_no_benefit>
What this research studies
This project aims to create programmable cells that only activate repair signals when they detect specific features of a degenerating joint. By using a synthetic biology approach, the cells should release regenerative factors directly in diseased areas, potentially slowing arthritis progression. The work involves engineering cell signaling pathways and testing how these cells behave in models that mimic human joint disease. If successful, this could lead to more durable joint repair with fewer systemic effects.
Why it matters
Potential benefit: If successful, patients with arthritis could experience better cartilage repair and slower disease progression.
How similar studies have gone: Preclinical cell engineering approaches have shown promise in directing cell behavior, but disease-responsive control remains a key challenge.
Where this research is happening
-
Vanderbilt University
Nashville, United States Active
Researchers
- Principal investigator: Brunger, Jonathan Matthew — Vanderbilt University
- Study coordinator: Brunger, Jonathan Matthew
Related research
Other NIH-funded projects on the same topics.
-
Gut microbes and methotrexate: boosting RA treatment through microbiome targets
Researchers are studying how gut bacteria affect how well methotrexate works for people with rheumatoid arthritis, aiming to make MTX effective for more patients.
-
Understanding how immune checkpoint drugs can trigger inflammatory arthritis in cancer patients
This research looks at why some cancer patients develop inflammatory arthritis after PD-1 inhibitor therapy and what could be done to prevent it.
-
Hybrid biomaterial system to boost immunotherapy for rheumatoid arthritis
A new, patient-facing immunotherapy approach uses specialized particles to retrain the immune system to calm RA in adults.
-
Dose guide for physical activity to improve arthritis symptoms
A study from the University of South Carolina will look at how different amounts of weekly physical activity affect arthritis symptoms and quality of life in adults with arthritis.
-
Collaborating Center for Arthritis Care Tools and a Coordinating Center for an Arthritis Management & Wellbeing Network
A coordinated NIH program aims to improve how primary care providers refer people with arthritis to evidence-based, self-management programs and to boost participation, especially among groups facing disparities.
-
Arthritis prevention program to help adults with OA in mountain west communities
A program to help adults with osteoarthritis in the Mountain West connect with physical activity counseling and community activities to reduce activity limitations.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.